Clinical trials - Page 1

Stay up to date with the latest Clinical trials updates from the global world pharmaceuticals industry

Latest Clinical trials Update

Diabetes drug alleviates anxiety in mice
05 June, 2019
The antidiabetic medication metformin reduces anxiety-like behaviours in...
> read more

Artificial intelligence provides boost to proteome research
Thursday, May 30, 2019 by Using artificial intelligence (AI), researchers at the Technical University of Munich (TUM) have developed software to analyse the proteins from any organism significantly faster and...

Clinical Innovation Partnership set for September, plus get 15% off here
Wednesday, May 29, 2019 by On 11 and 12 of September, Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials

Novel immunotherapy for lung cancer
Tuesday, February 19, 2019 by Researchers at the University of Louisville have been testing a protein-based molecule they originally developed to boost T cells as a cancer treatment. Whilst testing the...

New code of practice for pharma freebies
Wednesday, January 16, 2019 by On 1 January 2019, the new code of practice of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) came into effect

RAI Amsterdam to host CTS and PCT Europe
Wednesday, November 01, 2017 by RAI Amsterdam Convention Centre is the venue for Clinical Trial Supply 2017 and Partnerships in Clinical Trials Europe.

Autophagy gene linked to aggressive breast cancer
Monday, February 02, 2015 by A study by scientists from the University of Texas (UT) Medical Center suggests there is a strong link between triple-negative breast cancer - the most aggressive type of breast cancer...

New research reveals antibiotics could help treat cancer
Wednesday, January 28, 2015 by A researcher inspired by a conversation with his young child has discovered a means of eradicating cancer stem cells, using common antibiotics. Professor Michael P Lisanti, director...

Blood test doubles female heart attack diagnoses
Wednesday, January 21, 2015 by A potentially groundbreaking heart attack test could save women’s lives, according to recent research. A study funded by the British Heart Foundation and published in the British...

Daily aspirin could combat cancer
Wednesday, August 06, 2014 by A daily dose of 75-100 mg of aspirin could cut deaths from the major cancers of the digestive tract by as much as half, says research published in Annals of Oncology.A team from...

Nexavar given green light to treat thyroid cancer
Friday, May 30, 2014 by Nexavar, the drug developed by Bayer and Amgen unit Onyx Pharmaceuticals to treat advanced kidney and liver cancers, has been approved for the treatment of the most common form of...

Ipsen announces positive results from Dysport study
Wednesday, March 19, 2014 by Ipsen has announced positive results from its phase IIa clinical trial assessing Dysport® in the treatment of neurogenic detrusor overactivity (NDO) in patients with urinary...

Pfizer announces positive top-line results of landmark CAPiTA evaluating efficacy of Prevenar 13
Monday, February 24, 2014 by Pfizer Inc has announced that the 'Community-Acquired Pneumonia Immunisation Trial in Adults' (CAPiTA) − the landmark study of approximately 85,000 subjects evaluating the efficacy...

GSK announces start of Phase lll study for mepolizumab in patients with EGPA
Tuesday, February 18, 2014 by GlaxoSmithKline (GSK) has announced the start of a Phase III study to evaluate the efficacy and safety of mepolizumab, an investigational IL-5 antagonist, in patients with...

Editor's Choice By Category view all



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.